TransMedics Group, Inc. (TMDX)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch TMDX
See up to 3 months of TMDX. The 7-day demo opens the 1M and 3M ranges and puts TMDX on your watchlist.
Start 7-day demoLatest TMDX insider trades
About TransMedics Group, Inc. (TMDX)
TransMedics Group, Inc. files with the SEC under CIK 0001756262 and is classified as electromedical and electrotherapeutic apparatus. We track it alongside the rest of the Health Care sector.
TMDX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 1,336 | $109K |
| Bona-fide gift | 1 | 18,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
TMDX insider transactions (Form 4)
5637 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Weill - Director | Open-market purchase | Common Stock | 1,336 | $81.63 | $109K | |
| James R. Tobin - Director | Gift | Common Stock | 18,000 | $0.00 | - | |
 Nicholas Corcoran - Officer | Grant or award | Common Stock | 11,727 | $0.00 | - | |
| Nicholas Corcoran - Officer | Grant or award | Stock Option (Right to Buy) | 17,784 | $0.00 | - | |
| Gerardo Hernandez - Officer | Grant or award | Common Stock | 17,246 | $0.00 | - | |
| Gerardo Hernandez - Officer | Grant or award | Stock Option (Right to Buy) | 26,153 | $0.00 | - | |
 Waleed H. Hassanein - Officer | Grant or award | Common Stock | 49,669 | $0.00 | - | |
| Waleed H. Hassanein - Officer | Grant or award | Stock Option (Right to Buy) | 112,984 | $0.00 | - | |
| Thomas J. Gunderson | Option exercise | Common Stock | 19,285 | $2.21 | $43K | |
| Thomas J. Gunderson | Open-market sale | Common Stock | 9,624 | $75.06 | $722K | |
| Thomas J. Gunderson | Option exercise | Stock Option (Right to Buy) | 19,285 | $0.00 | - | |
 Stephanie Lovell | Grant or award | Common Stock | 2,922 footnote F1 | $0.00 | - | |
| ||||||
| David Weill | Grant or award | Common Stock | 2,922 footnote F1 | $0.00 | - | |
| ||||||
| Merilee Raines | Grant or award | Common Stock | 2,922 footnote F1 | $0.00 | - | |
| ||||||
| Thomas J. Gunderson | Grant or award | Common Stock | 2,922 footnote F1 | $0.00 | - | |
| ||||||
| Edward M. Basile | Grant or award | Common Stock | 2,922 footnote F1 | $0.00 | - | |
| ||||||
| James R. Tobin | Grant or award | Common Stock | 2,922 footnote F1 | $0.00 | - | |
| ||||||
| Edwin M. Kania Jr. | Grant or award | Common Stock | 2,922 footnote F1 | $0.00 | - | |
| ||||||
 Matthew S. Forsyth - Officer | Grant or award | Common Stock | 15,409 footnote F1 | $0.00 | - | |
| Matthew S. Forsyth - Officer | Grant or award | Stock Option (Right to Buy) | 23,171 | $0.00 | - | |
| ||||||
| Stephanie Lovell | Open-market sale | Common Stock | 1,193 | $149.62 | $178K | |
| David Weill | Option exercise | Common Stock | 3,571 | $14.20 | $51K | |
| David Weill | Open-market sale | Common Stock | 3,571 | $146.82 | $524K | |
| David Weill | Option exercise | Stock Option (Right to Buy) | 3,571 | $0.00 | - | |
| Gerardo Hernandez - Officer | Open-market sale | Common Stock | 5,912 | $147.21 footnote F2 | $870K | |
| Gerardo Hernandez - Officer | Option exercise | Stock Option (Right to Buy) | 1,324 | $0.00 | - | |
| Gerardo Hernandez - Officer | Option exercise | Stock Option (Right to Buy) | 5,912 | $0.00 | - | |
| Gerardo Hernandez - Officer | Option exercise | Common Stock | 1,324 | $77.12 | $102K | |
| Gerardo Hernandez - Officer | Option exercise | Common Stock | 5,912 | $69.84 | $413K | |
| Gerardo Hernandez - Officer | Open-market sale | Common Stock | 375 | $139.12 | $52K | |
| Gerardo Hernandez - Officer | Open-market sale | Common Stock | 1,324 | $147.21 footnote F2 | $195K | |
| ||||||
| Anil P. Ranganath - Officer | Open-market sale | Common Stock | 864 | $139.12 | $120K | |
| Nicholas Corcoran - Officer | Tax withholding / forfeiture | Common Stock | 984 footnote F1 | $135.30 | $133K | |
| Nicholas Corcoran - Officer | Open-market sale | Common Stock | 2,966 | $139.12 | $413K | |
| ||||||
 Giovanni Cecere - Officer | Grant or award | Common Stock | 11,082 footnote F1 | $0.00 | - | |
| Giovanni Cecere - Officer | Grant or award | Stock Option (Right to Buy) | 16,734 | $0.00 | - | |
| ||||||
| David Weill | Option exercise | Common Stock | 5,000 | $14.20 | $71K | |
| David Weill | Open-market sale | Common Stock | 5,000 | $138.64 | $693K | |
| David Weill | Option exercise | Stock Option (Right to Buy) | 5,000 | $0.00 | - | |
| Gerardo Hernandez - Officer | Open-market sale | Common Stock | 920 | $139.62 | $128K | |
| Anil P. Ranganath - Officer | Option exercise | Common Stock | 3,000 | $93.88 | $282K | |
| Anil P. Ranganath - Officer | Open-market sale | Common Stock | 3,000 | $145.22 footnote F1 | $436K | |
| Anil P. Ranganath - Officer | Option exercise | Stock Option (Right to Buy) | 3,000 | $0.00 | - | |
| ||||||
| Waleed H. Hassanein - Officer | Open-market purchase | Common Stock | 8,775 | $114.00 | $1.00M | |
| Edward M. Basile | Option exercise | Common Stock | 4,142 | $0.70 | $3K | |
| Edward M. Basile | Open-market sale | Common Stock | 4,142 | $130.45 | $540K | |
| Edward M. Basile | Option exercise | Stock Option (Right to Buy) | 4,142 | - footnote F3 | - | |
| ||||||
| Waleed H. Hassanein - Officer | Open-market purchase | Common Stock | 8,400 | $118.68 | $997K | |
| Waleed H. Hassanein - Officer | Open-market purchase | Common Stock | 6,617 | $116.08 | $768K | |
| Waleed H. Hassanein - Officer | Open-market purchase | Common Stock | 1,858 | $116.85 | $217K | |
| Edward M. Basile | Option exercise | Common Stock | 4,143 | $0.70 | $3K | |
| Edward M. Basile | Open-market sale | Common Stock | 4,143 | $125.51 | $520K | |
| Edward M. Basile | Option exercise | Stock Option (Right to Buy) | 4,143 | - | - | |
| Edwin M. Kania Jr. | Grant or award | Common Stock | 2,134 | $0.00 | - | |
| James R. Tobin | Grant or award | Common Stock | 2,134 | $0.00 | - | |
| Merilee Raines | Grant or award | Common Stock | 2,134 | $0.00 | - | |
Item 5.02, 7.01, 9.01
Item 2.02, 9.01
Item 5.07, 9.01
Item 2.02, 9.01
Recent TMDX Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
TMDX insider trading FAQ
What is the latest insider trade for TMDX?
TransMedics Group, Inc. (TMDX) had 2 insider filings in the last 90 days, with the most recent on 2026-09-14. The full record for TMDX runs to 37 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TMDX stock?
1 insider purchase of TMDX was filed in the last 90 days, totaling $109K.
How many insiders are selling TMDX stock?
No insider sales of TMDX were filed in the last 90 days. 31 sales are on record for this company.
Where can I see TMDX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TMDX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - David Weill view on EDGAR
- - James R. Tobin view on EDGAR
- - Nicholas Corcoran view on EDGAR
- - Gerardo Hernandez view on EDGAR
- - Waleed H. Hassanein view on EDGAR
- - Thomas J. Gunderson view on EDGAR
- - Stephanie Lovell view on EDGAR
- - David Weill view on EDGAR
- - Merilee Raines view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where TMDX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TMDX with a 7-day demo
- TMDX on your watchlist
- Every TMDX Form 4 filing on record
- Up to 3 months of TMDX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
